GoodRx Holdings, Inc.GDRXEarnings & Financial Report
GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx compares prescription drug prices at more than 75,000 pharmacies in the United States. The platform allows users to consult a doctor online and obtain a prescription for certain types of medications.
GDRX Q3 2025 Key Financial Metrics
Revenue
$196.0M
Gross Profit
N/A
Operating Profit
$14.6M
Net Profit
$1.1M
Gross Margin
N/A
Operating Margin
7.5%
Net Margin
0.6%
YoY Growth
0.4%
EPS
$0.00
Financial Flow
GoodRx Holdings, Inc. Q3 2025 Financial Summary
GoodRx Holdings, Inc. reported revenue of $196.0M for Q3 2025, with a net profit of $1.1M (0.6% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $196.0M |
|---|---|
| Net Profit | $1.1M |
| Gross Margin | N/A |
| Operating Margin | 7.5% |
| Report Period | Q3 2025 |
GoodRx Holdings, Inc. Annual Revenue by Year
GoodRx Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $792.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $792.3M |
| 2023 | $750.3M |
| 2022 | $766.6M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $196.6M | $197.9M | $200.6M | $195.3M | $198.6M | $203.0M | $203.1M | $196.0M |
| YoY Growth | 6.8% | 7.6% | 5.8% | 8.5% | 1.0% | 2.6% | 1.2% | 0.4% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.59B | $1.45B | $1.48B | $1.35B | $1.39B | $1.30B | $1.32B | $1.33B |
| Liabilities | $826.8M | $822.9M | $806.0M | $658.4M | $663.4M | $640.9M | $675.7M | $724.8M |
| Equity | $762.0M | $631.1M | $669.4M | $696.4M | $724.7M | $654.3M | $643.0M | $600.7M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $15.9M | $42.6M | $9.7M | $86.9M | $44.7M | $9.4M | $49.6M | $76.0M |
More Companies
EXAS
EXACT SCIENCES CORP
Revenue
$878.4M
Net Profit
$-86.0M
CBU
COMMUNITY FINANCIAL SYSTEM, INC.
Revenue
$207.1M
Net Profit
$55.1M
QDEL
QuidelOrtho Corp
Revenue
$699.9M
Net Profit
$-733.0M
PRTC
PureTech Health plc
CYH
COMMUNITY HEALTH SYSTEMS INC
Revenue
$3.1B
Net Profit
$130.0M
RCEL
AVITA Medical, Inc.
Revenue
$17.6M
Net Profit
$-11.6M
GOCO
GoHealth, Inc.
Revenue
$34.2M
Net Profit
$-165.8M